Hormonal dysregulation and bones in Thalassaemia - An overview

Pediatric Endocrinology Reviews

Volumn 6, Issue SUPPL. 1, 2008, Pages 107-115

  Skordis, Nicos ^a   Efstathiou, Elisavet ^a   Kyriakou, Andreas ^a   Toumba, Meropi ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

Author keywords

Endocrine complications; Thalassaemia

Indexed keywords

GROWTH HORMONE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE; SOMATOMEDIN C;

ADOLESCENCE; BONE DENSITY; BONE DISEASE; BONE GROWTH; BONE MASS; BONE REMODELING; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; MORBIDITY; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PROTEIN EXPRESSION; PUBERTY; REVIEW; THALASSEMIA MAJOR; VITAMIN D DEFICIENCY; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; BETA-THALASSEMIA; GONADAL STEROID HORMONES; HORMONES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OSTEOPOROSIS; OSTEOPROTEGERIN; RANK LIGAND;

EID: 58149479413     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Di Stefano M, Chiabotto P, Roggia C, Garofalo F, Lala R, Piga A, Isaia GC. Bone mass and metabolism in thalassaemic children and adolescents treated with different iron-chelating drugs. J Bone Miner Metab 2004;22:53-57
2. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 2004;123:730-737
3. Olivieri, NF, Koren G, Harris J, Khattak S, Freedman MH, Templeton DM, Bailey JD, Reilly BJ. Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 1992;14:48-56
4. De Virgillis S, Congio M, Frau F, Argiolu F, Diana G, Cucca F, Varsi A, Sanna G, Podda G, Fodde M, Pirastu GF, Cao A. Desferrioxamine induced growth retardation in patients with thalassaemia major. J Pediatr 1988;113:661-669
5. Aarden EM, Burger EH, Nijweide PJ. Function of osteocytes in bone. J Cell Biochem 1994;55:287-294
6. Lacey DL, Erdmann JM, Teitelbaum SL, Lacey DL, Tan HL, Ohara J, Shioi A. Interleukin-4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 1995;136:2367-2372
7. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001;166:4915-4922
8. Mirosavljevic D, Quinn M, Elliott J. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis. J Bone Miner Res 2003;18:984-992
9. Steelman J, Zeitler P. Osteoporosis in pediatrics. Pediatr Rev 2001;22:56-65
10. Javaid MK, Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab 2002;16:349-367
11. Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine regulation of the growth plate. Horm Res 2005;64:157-165
12. Wuster C. Growth hormone and bone metabolism. Acta Endocrinol (Copenh)1993;128(Suppl 2):14-18
13. Inzucchi SE, Robbins RJ. Effects of growth hormone on human biology. J Clin Endocrinol Metab 1994;79:691-694
14. Colao A, Disoma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Cornelli G, Ghigo E, and Lombarti G. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999;84:1919-1924
15. Cecconi E, Gasperi M, Genovesi M, Bogazzi F, Grasso L, Cetani, F Procopio M, Marcocci C, Bartalena L and Martino E. The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment. Eur J Endocrinol 2006;155:41-45
16. Niu T, Rosen JC. The insulin growth factor-I gene and osteoporosis; a critical appraisal. Gene 2005;361:38-56
17. Chagin AS, Savendahl L. Estrogens and growth: review. Ped Endocrinol Rev 2007;4:329-334
18. Gennari L, Merlotti D, Martini G, Gonnelli S, Franci B, Campagna S, Lucani B, Dal Canto N, Valenti R, Gennari C, Nuti R. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab 2003;88:5327-5333
19. Bilezician J, Morishima A, Bell J, Grumbach M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 2005;339:599-603
20. Smith P, Boyd J, Frank R, Takahashi H, Cohen M, Specker B, Williams C, Lubahn B, Korach S. Estrogen resistance caused by a mutation in the estrogen - receptor gene in a man. N Engl J Med 1994;331:1056-1061
21. Orhan K, Zerwekh E, Fisher C, Graves K, Nanu L, Millsaps R, Simpson E. Bone has a sexually dimorphic response to aromatase deficiency. J Bone Min Res 2000;15:507-512
22. Kearns AE and Khosla S. Potential anabolic effects of androgens on bone. Mayo Clin Proc 2004;79(Suppl):14-18
23. Vega D, Maalouf NM, Sakhaee K. Clinical review: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 2007;92:4514-4521
24. Salama OS, Al-Tonbary YA, Shahin RA, Eldeen OA. Unbalanced bone turnover in children with beta-thalassemia. Hematol 2006;11:197-202
25. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D. Bone resorption is increased in young adults with thalassemia major. Br J Haematol 2001;112:36-41
26. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. British Journal of Haematology 2000;111,902-907
27. Lasco A, Cannavò S, Gaudio A, Morabito N, Trifiletti A, Di Cesare E, Basile G, Nicita-Mauro V, Frisina N. Raloxifene and pituitary secretion in post-menopausal women. J Endocrinol Invest 2002;25(Suppl 10):95-96
28. Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone Min Res 2004;19:722-727
29. Voskaridou E, Terpos E, Spina G, Palermos J, Rahemtulla A, Loutradi A, Loukopoulos D. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Br J Haematol 2003;123:730-737
30. Riggs BL. The mechanisms of estrogen regulation of bone resorption. J Clin Invest 2000;106:203-204
31. Olszynski W, Shawn D, Davison K, Adachi D, Brown P, Cummin R, Hanley D, Harris P, Hodsman B, Kendler D, McClung R, Miller D, Yuen K. Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Therap 2004;26:15-28
32. Jensen E, Tuck M, Agnew E, Koneru S, Morris W, Yardumian A, Prescott E, Hoffbrand V, Wonke B. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998;103:911-915
33. Angastiniotis M, Pavlides N, Aristidou K, Kanakas A, Yerakaris M, Eracleous E, Posporis T. Bone pain in thalassaemia: assessment of DEXA and MRI findings. J Pediatr Endocrinol Metab 1998;11:779-784
34. Anapliotou M, Kastanias T, Psara P, Evangelou A, Liparaki M, Dimitriou P. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol 1985;42:279-287
35. Mylona M, Leotsinides M, Alexandrides T, Zoumbos N, Dimopoulos PA. Comparison of DXA, QCT and trabecular structure in beta-thalassaemia. Eur J Haematol 2005;74:430-437
36. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Multi-centre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol (Oxf) 1995;42:581-586
37. Skordis N, Gourni M, Kanaris C, Toumba M, Kleanthous M, Karatzia N, Pavlides N, Angastiniotis M. The impact of iron overload and genotype on gonadal function in women with thalassaemia major. Pediatr Endocrinol Rev 2004;2(Suppl 2):292-295
38. Skordis N, Petrikkos L, Toumba M, Siammonian K, Hadjgavriel M, Sitarou M, Kolnakou A, Skordos G, Pangalou E, Christou S. Update on fertility in thalassaemia. Pediatr Endocrinol Rev 2004;2(Suppl 2):296-302
39. Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with thalassaemia major. Pediatr Endocrinol Rev 2007;5:642-648
40. De Sanctis V, Vullo C, Katz M, Wonke B, Tanaw R, Bagni B. Gonadal function in patients with beta-thalassaemia major. J Clin Pathol 1988;41:133-137
41. Perera D, Pizzey A, Campbell A, Katz M, Porter J, Petrou M, Irvine DS, Chatterjee R. Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. Hum Reprod 2002;17:1820-1825
42. Berkovitch M, Bistritzer T, Milone S, Periman K, Kucharczk W, Koren G, Otivied NF. Iron deposition in the anterior pituitary in homozygous beta-thalassaemia: MRI evaluation and correlation with gonadal function. J Pediatr Endocrinol Metab 2000;13;179-184
43. Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, Skordos G, Christou S. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol 2006;77:150-156
44. Filosa A, Di Maio S, Vocca S, Saviano A, Esposito G, Pagano L. Longitudinal monitoring of bone mineral density in thalassemic patients. Genetic structure and osteoporosis. Acta Paediatr 1997;86:342-346
45. Lala R, Chiabotto P, Di Stefano M, Isaia GC, Garofalo F, Piga A. Bone density and metabolism in thalassaemia. J Pediatr Endocrinol Metab 1998;11(Suppl 3):785-790
46. Bielinski K, Darbyshire J, Mathers L, Crabtree J, Kirk M, Stirling F, Shaw J. Impact of disordered puberty on bone density in beta-thalassaemia major. Br J Haematol 2003;120:353-358
47. Vogiatzi G, Autio A, Mait E, Schneider R, Lesser M, Giardina P. Low bone mineral density in adolescents with beta-thalassemia. Ann NY Acad Sci 2005;1054:462-466
48. Benigno V, Bertelloni S, Baroncelli GI, Bertacca L, Di Peri S, Cuccia L, Borsellino Z, Maggio MC. Effects of thalassemia major on bone mineral density in late adolescence. J Pediatr Endocrinol Metab 2003;16(Suppl 2):337-342
49. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A, Rajatanavin R. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clin Endocrinol (Oxf) 2003;58:273-279
50. Lasco A, Morabito N, Gaudio A, Bruno M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta thalassemia major. Osteoporos Int 2001;12:570-575
51. Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB. Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int 2004;74:68-71
52. Savine R, Sonksen P. Growth hormone - hormone replacement for the somatopause? Horm Res 2000;53(Suppl 3):37-41
53. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 1993;52:222-226
54. Digirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL. Mode of growth hormone action in osteoblasts. J Biol Chem 2007;282:1666-1674
55. Li H, Bartold M, Zhang Z, Clarkson W, Young G, Waters J. Growth hormone and insulin-like growth factor-1 induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation. Endocrinol 1998;139:3855-3862
56. Mrak E, Villa I, Lanzi R, Losa M, Guidobono F, Rubinacci A. Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells. J Endocrinol 2007;192:639-645
57. McCarthy TL, Centrella M, Canalis E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinol 1989;124:301-309
58. Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K, Kumegawa M. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 1992;131:1075-1080
59. Leger J, Girot R, Crosnier H, Poste-Vinay MC, Rappaport R. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassaemia major before puberty: a possible age related effect. J Clin Endocrinol Metab 1989;69:453-456
60. Soliman T, El Banna N, Ansari M. GH response to provocation and circulating IGF-1 and IGF-binding protein-3 concentrations, the IGF-1 generation test and clinical response to GH therapy in children with beta-thalassaemia. Eur J Endocrinol 1998;138:394-400
61. De Luca G, Maggiolini M, Bria M, Caracciolo M, Giorno A, Salemo M, Marisco S, Lanzino M, Brancati C, Ando S. GH secretion in thalassaemia patients with short stature. Horm Res 1995;44:158-163
62. De Sanctis V. Growth and puberty in thalassaemia. Horm Res 2002;58(Suppl 1):72-79
63. Leheup BP, Cisternino M, Bozzola M, Donsset B, Marvadi PL, Antoniazzi F, Tato L, Severi F, Sommelet D, Pierson M. Growth hormone response following growth hormone releasing hormone injection in thalassaemia major: influence of pubertal development. J Endocrinol Invest 1991;14:37-40
64. Shehadeh N, Hazani A, Rudolf MCJ, Peleg I, Benderly A, Hochberg Z. Neurosecretory dysfunction of growth hormone secretion in thalassaemia major. Acta Paediatr Scand 1990;79:790-795
65. Karamifar H, Karimi M, Amirhakimi G, Sharbatialaei M, De Sanctis V. Reduced insulin growth factor I concentrations in iron-overloaded beta thalassaemic patients with normal growth hormone secretion and liver function. Pediatr Endocrinol Rev 2004;2(Suppl 2):256-258
66. Scacchi M, Danesi L, Cattaneo A, Valassi E, Pecori Giraldi F, Argento C, D'Angeto E, Mirra N, Carnelli V, Zanaboni L, Cappellini MD, Cavagnini F. Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf) 2007;67:790-795
67. Scacchi M, Danesi L, Cattaneo A, Valassi E, Giraldi FP, Argento C, D'Angelo E, Mirra N, Carnelli V, Zanaboni L, Tampieri B, Cappellini MD, Cavagnini F. Bone demineralization in adult thalassaemic patients. Contribution of growth hormone and insulin-like growth factor I at different skeletal sites. Clin Endocrinol (Oxf) 2008;69:202-207
68. La Rosa C, De Sanctis V, Mangiagli A, Mancuso M, Guardabasso V, Galati MC, Caruso-Nicoletti M. Growth hormone secretion in adult patients with thalassaemia. Clin Endocrinol (Oxf) 2005;62:667-671
69. Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major. J Endocrinol Invest 2000;23;356-361
70. Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G. Hypoparathyroidism in transfusion-dependent patients with beta-thalassaemia. J Bone Miner Metab 2006;24:138-145
71. Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracerebral calcification in patients with beta-thalassaemia major. J Pediatr Endocrinol Metab 2003;16:883-886
72. Rioja L, Girot R, Garabédian M, Cournot-Witmer G. Bone disease in children with homozygous beta-thalassemia. Bone Miner 1990;8:69-86
73. De Vernejoul C, Girot R, Gueris J, Cancela L, Bang S, Bielakoff J, Mautalen C, Goldberg D, Miravet L. Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab 1982;54:276-281
74. Moulas A, Challa A, Chaliasos N, Lapatsanis PD. Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr 1997;86:594-549
75. Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 2006;38:888-889
76. Praticò G, Di Gregorio F, Caltabiano L, Palano GM, Morana M, Caruso-Nicoletti M. Bone metabolism markers in thalassemia. Pediatr Med Chir 2001;23:35-39
77. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A, Rajatanavin R. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clin Endocrinol (Oxf). 2003;58:273-279
78. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 2003;88:3966-3972